Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort
Gorlin syndrome is a genetic condition associated with the occurrence of SHH activated medulloblastoma, basal cell carcinoma, macrocephaly and other congenital anomalies. It is caused by heterozygous pathogenic variants in PTCH1 or SUFU. In this study we included 16 patients from the HIT2000, HIT200...
Guardado en:
Autores principales: | Katja Kloth, Denise Obrecht, Dominik Sturm, Torsten Pietsch, Monika Warmuth-Metz, Brigitte Bison, Martin Mynarek, Stefan Rutkowski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ee8156c703b490f85d58c2bffe999f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Síndrome de Gorlin-Goltz: Una presentación atípica
por: Moyano M,Daniel, et al.
Publicado: (2016) -
Gorlin-Goltz Syndrome: The importance of Clinical Investigation and a Multidisciplinary Approach
por: Bachesk,Andressa Bolognesi, et al.
Publicado: (2021) -
Immunohistochemical Analysis of Human Homologue of Drosophila Patched (PTCH) in Dental Follicles of Impacted Third Molars
por: Oliveira,David Moraes de, et al.
Publicado: (2012) -
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Marije J. Voskamp, et al.
Publicado: (2021) -
Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland
por: Marek W. Karwacki
Publicado: (2020)